FDA Launches Elsa Generative AI Tool to Assist Agency Employees

FDA announced the launch of a new internal tool called Elsa, a generative AI system built to support agency staff in handling routine documentation, data analysis, and other repetitive tasks, with the goal of improving overall efficiency and reducing manual workload across multiple departments.

Elsa is described as a generative artificial intelligence application capable of producing text and drafting responses, allowing employees to cut down the time spent on repetitive writing, streamline internal communications, and focus more on higher‑level regulatory and scientific evaluation work.

Employees will access Elsa through the FDA’s secure internal network, with training sessions scheduled to integrate the tool into daily workflows, ensure compliance with agency standards, and monitor its performance as part of the department’s broader digital modernization efforts.

Facebook posted a video release that details the launch, highlighting Elsa’s role in modernizing the agency’s operations, demonstrating the FDA’s commitment to adopting advanced AI technologies, and signaling a shift toward greater use of generative AI within government functions.